Ep.61 - The number one red flag when looking for a GLP provider episode artwork

EPISODE · May 22, 2026 · 27 MIN

Ep.61 - The number one red flag when looking for a GLP provider

from The FastFit® Podcast · host FastFit™

The side effects people associate with GLPs are overwhelmingly tied to dosing too aggressively. Semaglutide (GLP only) is what she calls “inelegant and clunky.” Tirzepatide (GLP + GIP) is more complete, better tolerated, and effective at lower doses. Retatrutide (GLP + GIP + glucagon) is coming later this year for patients who are metabolically inflexible and resistant to tirzepatide.

Episode metadata supplied by the publisher feed · Published May 22, 2026

Embed this episode

Ready to play

Ep.61 - The number one red flag when looking for a GLP provider

0:00 27:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The FastFit® Podcast?

This episode is 27 minutes long.

When was this The FastFit® Podcast episode published?

This episode was published on May 22, 2026.

Can I download this The FastFit® Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!